VANGUARD GROUP INC - RUBIUS THERAPEUTICS INC ownership

RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 8 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of RUBIUS THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$293,417
-60.3%
1,676,669
-1.7%
0.00%
Q3 2022$740,000
-55.1%
1,705,288
-12.0%
0.00%
Q2 2022$1,648,000
-87.2%
1,937,193
-16.9%
0.00%
Q1 2022$12,843,000
-59.1%
2,330,725
-28.2%
0.00%
-100.0%
Q4 2021$31,427,000
-45.7%
3,246,641
+0.4%
0.00%0.0%
Q3 2021$57,843,000
-26.9%
3,235,007
-0.2%
0.00%
-50.0%
Q2 2021$79,148,000
-3.6%
3,242,403
+4.6%
0.00%0.0%
Q1 2021$82,113,000
+349.2%
3,098,602
+28.6%
0.00%
+100.0%
Q4 2020$18,281,000
+54.0%
2,408,755
+1.7%
0.00%
Q3 2020$11,869,000
-37.2%
2,369,274
-25.0%
0.00%
-100.0%
Q2 2020$18,892,000
+41.3%
3,159,130
+5.1%
0.00%0.0%
Q1 2020$13,370,000
-52.9%
3,004,433
+0.5%
0.00%0.0%
Q4 2019$28,392,000
+24.6%
2,988,657
+2.9%
0.00%0.0%
Q3 2019$22,795,000
-46.8%
2,903,831
+6.5%
0.00%
-50.0%
Q2 2019$42,876,000
+12.2%
2,725,717
+29.1%
0.00%
+100.0%
Q1 2019$38,209,000
+139.0%
2,110,958
+112.3%
0.00%0.0%
Q4 2018$15,987,000
-31.5%
994,249
+2.3%
0.00%0.0%
Q3 2018$23,329,000972,0320.00%
Other shareholders
RUBIUS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 38,506,526$6,546,1090.21%
HARBOURVEST PARTNERS LLC 986,878$172,7040.06%
Artal Group S.A. 2,042,666$3570.02%
Virtu Financial LLC 68,825$120.00%
ACADIAN ASSET MANAGEMENT LLC 1,277,196$2220.00%
STATE OF MICHIGAN RETIREMENT SYSTEM 640,000$110,1440.00%
Baillie Gifford 4,869,126$837,9770.00%
Citadel Advisors 600$1030.00%
Tower Research Capital LLC (TRC) 25$00.00%
JPMORGAN CHASE & CO 2,196$00.00%
View complete list of RUBIUS THERAPEUTICS INC shareholders